The Dallas Asthma Brain and Cognition Study (Dallas ABC Study)

达拉斯哮喘大脑和认知研究(达拉斯 ABC 研究)

基本信息

  • 批准号:
    10219346
  • 负责人:
  • 金额:
    $ 72.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-15 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Abstract Asthma is a chronic inflammatory airway disease, with an increasing prevalence, that is associated with a substantial burden on quality of life for patients and financial burden on society. Despite progress in the pharmacological treatment, overall asthma control remains unsatisfactory and treatment non-adherence is extremely high. The available research, much of which was conducted by investigators on this proposal, suggests that asthma may be associated with changes in brain structure and biochemistry, as well as increased risk for cognitive impairment and dementia. However, little is known about the impact of asthma on cognitive function and associated central nervous system processes, especially for in middle- to older age patients. Prior research has also not characterized the relationship between key domains of cognitive function and possible changes in brain structure, chemistry, and function specific to asthma. Additionally, the role of biobehavioral factors (such as mood, sleep, or inflammation) and asthma-specific factors (severity, duration, medication, airway inflammation) in explaining some of these deficits in asthma and aging has not been explored. We therefore propose to compare 126 adults 40-69 years old, diagnosed with asthma, and stratified for age (three decades) and asthma severity, with 66 age-matched non-asthmatic controls using cognitive tests that include processing speed, episodic memory, and executive function. Participants will also undergo neuroimaging. Structural magnetic resonance imaging (MRI) will focus on hippocampal volume. Diffusion tensor imaging (DTI) will be used to measure integrity of white matter integrity, which is associated with processing speed. Proton magnetic resonance spectroscopy (1HMRS) will measure metabolites linked to neuronal degeneration (N-acetyl aspartate, NAA) and glial inflammation (myo-inositol, mI). Three functional MRI scans will measure brain activity under different cognitive conditions: (a) a resting state scan to examine functional connectivity of brain networks; (b) a subsequent memory task to assess the role of hippocampal activation in the service of memory encoding, and (c) a modulation task that measures the ability of the cognitive control network to increase brain activity in fronto-parietal regions as task demands increase. We will also examine whether cognitive impairments are mediated by distinct brain changes extrapolated from prior research on aging and pilot research on respiratory disease. In addition, we will study a potential role of depressive mood, sleep quality and systemic inflammation, as well as asthma-relevant variables in mediating these associations. We hypothesize that asthma patients, compared to controls, will demonstrate accelerated brain aging as demonstrated by cognitive deficits and brain changes, which increase in magnitude with older age. Thus, this proposal will provide fundamental information to develop future preventative and intervention efforts to mitigate the potentially adverse effects of asthma on brain and cognition. A multidisciplinary research team with extensive experience in mental health in asthma patients, as well as neuroimaging across the lifespan will conduct the study.
抽象的 哮喘是一种慢性炎症性气道疾病,患病率越来越高,与 患者的生活质量和社会经济负担很大。尽管进展 药理治疗,总体哮喘控制仍然不令人满意,不遵守治疗是 极高。可用的研究,其中大部分是由调查人员就此提案进行的 表明哮喘可能与大脑结构和生物化学的变化以及 认知障碍和痴呆症的风险增加。但是,关于哮喘对哮喘的影响知之甚少 认知功能和相关的中枢神经系统过程,尤其是在中年至更大的年龄 患者。先前的研究还没有表征认知功能的关键领域之间的关系 以及大脑结构,化学和功能的可能变化。另外, 生物行为因素(例如情绪,睡眠或炎症)和哮喘特异性因素(严重程度,持续时间, 药物,气道炎症)解释哮喘和衰老中的一些缺陷 探索。因此,我们建议比较40-69岁的126名成年人,被诊断为哮喘和分层 对于年龄(三十年)和哮喘的严重程度,使用认知测试具有66个年龄匹配的非心律对照 其中包括处理速度,情节记忆和执行功能。参与者也会经历 神经影像学。结构磁共振成像(MRI)将集中在海马体积上。扩散 张量成像(DTI)将用于测量白质完整性的完整性,这与 处理速度。质子磁共振光谱(1HMR)将测量与 神经元变性(N-乙酰基天冬氨酸,NAA)和神经胶质炎症(Myo-Insitol,MI)。三个功能 MRI扫描将在不同的认知条件下测量大脑活动:(a)静止状态扫描以检查 大脑网络的功能连通性; (b)随后评估海马作用的记忆任务 在为内存编码服务中激​​活,以及(c)调制任务,以测量 随着任务需求的增加,认知控制网络以增加额顶区域的大脑活动。我们将 还要检查认知障碍是否是由从先前推断的不同大脑变化介导的 关于呼吸道疾病衰老和试点研究的研究。此外,我们将研究 抑郁情绪,睡眠质量和全身性炎症,以及与哮喘相关的变量 这些关联。我们假设与对照组相比,哮喘患者将表现出加速 认知缺陷和大脑变化所证明的大脑衰老,随着年龄较大的幅度增加 年龄。因此,该提案将提供基本信息,以开发未来的预防和干预 减轻哮喘对大脑和认知的潜在不利影响的努力。一项多学科研究 在哮喘患者中具有丰富心理健康经验的团队,以及在整个哮喘患者中的神经影像 寿命将进行研究。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Boosting nitric oxide in stress and respiratory infection: Potential relevance for asthma and COVID-19.
  • DOI:
    10.1016/j.bbih.2021.100255
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ritz T;Salsman ML;Young DA;Lippert AR;Khan DA;Ginty AT
  • 通讯作者:
    Ginty AT
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

E SHERWOOD BROWN其他文献

E SHERWOOD BROWN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('E SHERWOOD BROWN', 18)}}的其他基金

T35 NIAAA Summer Research Program
T35 NIAAA 夏季研究计划
  • 批准号:
    10627715
  • 财政年份:
    2023
  • 资助金额:
    $ 72.55万
  • 项目类别:
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging
使用神经认知测试和高分辨率脑成像探索皮质类固醇对人类海马的影响
  • 批准号:
    10333336
  • 财政年份:
    2019
  • 资助金额:
    $ 72.55万
  • 项目类别:
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging
使用神经认知测试和高分辨率脑成像探索皮质类固醇对人类海马的影响
  • 批准号:
    10556437
  • 财政年份:
    2019
  • 资助金额:
    $ 72.55万
  • 项目类别:
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging
使用神经认知测试和高分辨率脑成像探索皮质类固醇对人类海马的影响
  • 批准号:
    10091987
  • 财政年份:
    2019
  • 资助金额:
    $ 72.55万
  • 项目类别:
Exploring the Effects of Corticosteroids on the Human Hippocampus using Neurocognitive Testing and High-Resolution Brain Imaging
使用神经认知测试和高分辨率脑成像探索皮质类固醇对人类海马的影响
  • 批准号:
    9898466
  • 财政年份:
    2019
  • 资助金额:
    $ 72.55万
  • 项目类别:
A Neurosteroid Intervention for Menopausal and Perimenopausal Depression
神经类固醇干预治疗更年期和围绝经期抑郁症
  • 批准号:
    10359033
  • 财政年份:
    2018
  • 资助金额:
    $ 72.55万
  • 项目类别:
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder
多巴胺 2 受体部分激动剂治疗双相情感障碍和酒精使用障碍
  • 批准号:
    9976319
  • 财政年份:
    2016
  • 资助金额:
    $ 72.55万
  • 项目类别:
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder
多巴胺 2 受体部分激动剂治疗双相情感障碍和酒精使用障碍
  • 批准号:
    9522094
  • 财政年份:
    2016
  • 资助金额:
    $ 72.55万
  • 项目类别:
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder
多巴胺 2 受体部分激动剂治疗双相情感障碍和酒精使用障碍
  • 批准号:
    9175896
  • 财政年份:
    2016
  • 资助金额:
    $ 72.55万
  • 项目类别:
Dopamine-2 Receptor Partial Agonist for Bipolar Disorder and Alcohol Use Disorder
多巴胺 2 受体部分激动剂治疗双相情感障碍和酒精使用障碍
  • 批准号:
    9352266
  • 财政年份:
    2016
  • 资助金额:
    $ 72.55万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
  • 批准号:
    10649012
  • 财政年份:
    2023
  • 资助金额:
    $ 72.55万
  • 项目类别:
Dysregulated Immunometabolism and Premature Senescence in Corticosteroid-Refractory Severe Asthma
皮质类固醇难治性严重哮喘的免疫代谢失调和过早衰老
  • 批准号:
    10567868
  • 财政年份:
    2023
  • 资助金额:
    $ 72.55万
  • 项目类别:
An Alternative Pathobiology underlying Severe Asthma
严重哮喘的替代病理学
  • 批准号:
    10736884
  • 财政年份:
    2023
  • 资助金额:
    $ 72.55万
  • 项目类别:
Development of small molecule Protease-activated-receptor-2 antagonists as oral asthma therapeutics
开发小分子蛋白酶激活受体 2 拮抗剂作为口服哮喘治疗药物
  • 批准号:
    10766584
  • 财政年份:
    2023
  • 资助金额:
    $ 72.55万
  • 项目类别:
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
  • 批准号:
    10558633
  • 财政年份:
    2022
  • 资助金额:
    $ 72.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了